Skip to search formSkip to main contentSkip to account menu

Carmustine 7.7 MG Drug Implant [Gliadel]

Known as: BCNU 7.7 MG Drug Implant [Gliadel], CARMUSTINE 7.7 mg INTRACAVITARY WAFER [Gliadel], Gliadel Wafer 7.7 MG Intracavitary Drug Implant 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Direct delivery of chemotherapy agents to the brain via degradable polymer delivery systems—such as Gliadel®—is a clinically… 
Review
2007
Review
2007
Malignant gliomas are very difficult neoplasms for clinicians to treat. The reason for this is multifaceted. Many treatments that… 
Review
2007
Review
2007
Malignant gliomas represent the majority of primary brain tumors, and the prognosis of the patients afflicted with these tumors… 
Review
2004
Review
2004
New approaches to malignant glioma are being actively investigated. Local drug delivery directly to the site of the tumor is one… 
Highly Cited
1995
Highly Cited
1995
BACKGROUND Mapping of endocardial activation is an important procedure for diagnosing cardiac arrhythmias and locating the… 
Highly Cited
1989
Highly Cited
1989
The correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic embolism was studied… 
Highly Cited
1988
Highly Cited
1988
Thirty-five patients with superficial transitional carcinoma of the bladder were treated intravesically with escalating doses of…